First Horizon Pharmaceutical Corporation Names Ed Schutter as New Executive Vice President, Chief Commercial Officer

First Horizon Pharmaceutical Corporation (NASDAQ:FHRX)
today announced that Edward Schutter has joined the Company as
Executive Vice President, Chief Commercial Officer. Schutter will
report to Patrick Fourteau, President and Chief Executive Officer, and
will serve as a member of the Company's senior executive team.
   "We are delighted that Ed has joined the Company in this newly
created position," said Mr. Fourteau. "We look forward to his
leadership in managing the sales and marketing and business
development functions of our pharmaceutical operations."
   Schutter brings over 20 years of pharmaceutical experience to the
Company. He most recently served as Vice President, Global Business
Development and Licensing at Solvay Pharmaceuticals, based in Basel,
Switzerland. During his tenure with Solvay, Schutter also served in
various commercial roles, including National Sales Director, Marketing
Director and Director of Managed Care Sales.
   Schutter received a Bachelor of Science in Pharmacy from Mercer
University and an MBA from Kennesaw State University. He will be based
in the Company's home office in Alpharetta, Georgia.
   First Horizon is a specialty pharmaceutical company that markets,
develops and sells brand name prescription products for the primary
service of cardiology and women's health. First Horizon has a
portfolio that includes 15 branded products, of which eight are
actively promoted to high prescribing physicians through its
nationwide sales force of approximately 525 representatives. First
Horizon's website address is www.fhrx.com, but information contained
therein is not part of this press release.